Tiansheng Pharmaceutical Group Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 404.75 million compared to CNY 601.84 million a year ago. Revenue was CNY 404.75 million compared to CNY 601.84 million a year ago.

Net loss was CNY 62.58 million compared to CNY 67.84 million a year ago. Basic loss per share from continuing operations was CNY 0.1968 compared to CNY 0.2133 a year ago. Diluted loss per share from continuing operations was CNY 0.1968 compared to CNY 0.2133 a year ago.